Motor neurons with ALS proteostasis stress may upregulate ACSL4/LPCAT3-dependent PUFA-phospholipid remodeling, creating membranes that are unusually sensitive to iron-catalyzed peroxidation. Inhibiting this substrate-loading step should lower ferroptosis without broad iron depletion.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
flowchart TD
A["ALS proteostasis stress"] --> B["ACSL4 upregulation"]
B --> C["LPCAT3 activity enhanced"]
C --> D["PUFA-phospholipid remodeling"]
D --> E["Ferroptosis-prone membrane lipid composition"]
E --> F["Iron accumulation in motor neurons"]
F --> G["Iron-catalyzed lipid peroxidation"]
G --> H["Ferroptosis execution"]
H --> I["Motor neuron degeneration"]
J["ACSL4 inhibition"] --> K["Reduced PUFA membrane loading"]
K --> L["Lower ferroptosis sensitivity"]
J -->|" blocks "| C
J -->|" prevents "| D
L --> M["Protected motor neuron survival"]
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
3 citations0 with PMIDValidation: 57%2 supporting / 1 opposing
✓For(2)
No supporting evidence
No opposing evidence
(1)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
3
MECH 3CLIN 0GENE 0EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
No claim
Supporting
MECH
Increased Vulne…
-
2024
-
-
-
No claim
Supporting
MECH
Lipid peroxidat…
-
-
-
-
-
No claim
Opposing
MECH
-
-
-
-
-
-
Legacy Card View — expandable citation cards
✓ Supporting Evidence
2
No claim
Increased Vulnerability to Ferroptosis in FUS-ALS · 2024
No claim
Lipid peroxidation products are elevated in ALS tissue and biofluids
✗ Opposing Evidence
1
No claim
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-26 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Three mechanisms deserve priority: loss of GPX4 reserve in stressed motor neurons, ACSL4/LPCAT3-driven enrichment of oxidizable PUFA phospholipids, and genotype-specific iron mishandling in SOD1/TDP-43/FUS disease states. Each is testable with lipidomics plus ferroptosis-rescue controls.
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
The key weakness is causal ordering. Lipid peroxidation appears in many dying neurons, so experiments must show that ferroptosis blockade rescues motor-neuron survival after controlling for apoptosis, necroptosis, mitochondrial collapse, and inflammatory toxicity.
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Translation requires biomarkers before treatment trials: CSF/plasma 4-HNE, F2-isoprostanes, oxidized PE species, GPX4 activity, and iron MRI should stratify patients. Deferiprone-like strategies need careful anemia and mitochondrial safety monitoring.
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
Ranked synthesis: prioritize GPX4 reserve failure, then PUFA-phospholipid substrate loading, then labile iron pool expansion. The program should demand orthogonal death-pathway exclusion and genotype-aware rescue studies.